Incorporating PCI Following ADRIATIC Study

Opinion
Video

Following recent data from the ADRIATIC study, the Oncology Brothers and Eric Singhi, MD, discuss the role of prophylactic cranial irradiation (PCI) in patients with small cell lung cancer.

Recent Videos
The Onc Brothers feature one guest in this series.
The Onc Brothers feature one guest in this series.
The Onc Brothers feature one guest in this series.
The Onc Brothers feature one guest in this series.
The Onc Brothers feature one guest in this series.
Pallawi Torka, MD, with the Oncology Brothers presenting slides
Pallawi Torka, MD, with the Oncology Brothers presenting slides
Pallawi Torka, MD, with the Oncology Brothers presenting slides
Pallawi Torka, MD, with the Oncology Brothers presenting slides
Carla Casulo, MD, with the Oncology Brothers presenting slides
Related Content
Supporting data for the designation comes from the ARTEMIS-001 trial evaluating preliminary safety and antitumor activity of GSK’227 in solid tumors.

FDA Grants Breakthrough Therapy Designation to GSK’227 in ES-SCLC

Roman Fabbricatore
August 23rd 2024
Article

Supporting data for the designation comes from the ARTEMIS-001 trial evaluating preliminary safety and antitumor activity of GSK’227 in solid tumors.

Practices are on the cusp of better understanding small cell lung cancer that in turn can help to advance treatment strategies for patients, says Gregory Peter Kalemkerian, MD.

Updated ASCO Guidelines for Optimal Small Cell Lung Cancer Management

Gregory Peter Kalemkerian, MD
March 25th 2024
Podcast

Practices are on the cusp of better understanding small cell lung cancer that in turn can help to advance treatment strategies for patients, says Gregory Peter Kalemkerian, MD.

The overall survival data in the phase 3 KeyVibe-008 trial met the prespecified futility criteria.

Investigators Discontinue Vibostolimab Combo in Extensive-Stage SCLC Trial

Russ Conroy
August 9th 2024
Article

The overall survival data in the phase 3 KeyVibe-008 trial met the prespecified futility criteria.

In the final part of the small cell lung cancer podcast series, CancerNetwork® and Wade Iams, MD, discuss the future of treating patients with this disease.

Oncology Peer Review On-The-Go: Future Directions in Small Cell Lung Cancer Treatment

Matthew Fowler;Wade Iams, MD
December 22nd 2021
Podcast

In the final part of the small cell lung cancer podcast series, CancerNetwork® and Wade Iams, MD, discuss the future of treating patients with this disease.

FDA Grants Fast Track Designation to SNB-101 in Small Cell Lung Cancer

FDA Grants Fast Track Designation to SNB-101 in Small Cell Lung Cancer

Russ Conroy
May 10th 2024
Article

Treatment with SNB-101 previously demonstrated tolerability among patients with solid tumors in a phase 1 trial.

Treatment with durvalumab raises no new safety signals among patients with limited-stage small cell lung cancer in the phase 3 ADRIATIC trial.

Durvalumab Significantly Improves Survival in Limited-Stage SCLC

Russ Conroy
April 5th 2024
Article

Treatment with durvalumab raises no new safety signals among patients with limited-stage small cell lung cancer in the phase 3 ADRIATIC trial.